Promising role of EZH2 immunohistochemistry in detecting aggressive types of thymic epithelial tumors
Egyptian Journal of Pathology · 2026-01 · 46 (1) · 77-84
DOI: 10.4103/egjp.egjp_27_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Egyptian Journal of Pathology, online erschienen am 21.07.2026. Verfasst von Asmaa M. Eid und 1 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Thymomas are unique thymic epithelial tumors, displaying a range of types. Although all of these are considered malignant, they vary in biological behavior and aggressiveness, which reflects in therapeutic approaches and treatment regimens. EZH2 is implicated in carcinogenesis, angiogenesis, and tumor progression. Current work aimed to assess the diagnostic significance of EZH2 immunoexpression in thymic epithelial tumors, and to evaluate its relation to Ki-67 immunohistochemical expression. Materials and methods Seventy cases diagnosed as thymomas were retrieved from the Tanta University, Pathology Department, and private laboratories from November 2023 to November 2024. Cases were classified as: thymoma type A (five cases), thymoma type AB (10 cases), thymoma type B (35 cases), including thymoma type B1 (five cases), thymoma type B2 (15 cases), thymoma type B3 (15 cases), thymoma type C (20 cases). Immunostaining was performed using EZH2 and Ki-67 antibodies.
Results
EZH2 distinguished thymoma type C from type B3 at cut-off value of more than 70%, with a sensitivity of 95.0%, and a specificity of 93.33%. Moreover, EZH2 distinguished thymoma types B3 and type C from other types at a cut-off value of more than 30%, with a sensitivity of 97.14%, and aspecificity of 94.29%. Mean Ki-67 percentage area was 18.95 ± 0.95 in thymoma type C, 15.50 ± 0.73 in thymoma type B3. A significant relation was detected between EZH2 expression and Ki-67 percentage area.
Conclusion
EZH2 may be a valuable marker in detecting aggressive thymoma subtypes, highlighting its role in tumor classification. Incorporating EZH2 into standard diagnostic workup could improve patient stratification and guide personalized treatment strategies for thymic epithelial tumors.
Zitieren
APA
Eid, A. M., & Amer, A. I. (2026). Promising role of EZH2 immunohistochemistry in detecting aggressive types of thymic epithelial tumors. Egyptian Journal of Pathology, 46(1), 77-84. https://doi.org/10.4103/egjp.egjp_27_25
Vancouver
Eid AM, Amer AI. Promising role of EZH2 immunohistochemistry in detecting aggressive types of thymic epithelial tumors. Egyptian Journal of Pathology. 2026;46(1):77-84. doi:10.4103/egjp.egjp_27_25
BibTeX
@article{Eid2026,
author = {Eid, Asmaa M. and Amer, Alaa I.},
title = {Promising role of EZH2 immunohistochemistry in detecting aggressive types of thymic epithelial tumors},
journal = {Egyptian Journal of Pathology},
year = {2026},
volume = {46},
number = {1},
pages = {77--84},
doi = {10.4103/egjp.egjp_27_25}
}
EUVIMED